press-release · events · recognition
Annate Bitherapeutics CEO Eric DeJesus, PhD, joined Georgia Life Sciences in Washington, DC, for the Council of State Bioscience Associations Fly-In to advocate for policies that support innovation, patients, and U.S. biotech leadership. Read More ›
press-release · recognition
UGA Research spotlighted Annate Bitherapeutics in a feature on the personal story and scientific mission driving the company’s work to develop new cancer therapies. Read More ›
press-release · media · recognition
UGA Research News featured Annate Bitherapeutics for its work advancing a bispecific antibody platform designed to harness the innate human immune system against cancer. Read More ›
events · recognition · press-release
Annate Bitherapeutics earned top recognition and a $2,500 award at the University of Georgia’s Field to Fund: Where Innovation Meets Opportunity event, showcasing breakthrough cancer therapeutics alongside innovators from UGA and the University of Kentucky. Read More ›
events · recognition · press-release
Annate Bitherapeutics CEO Eric DeJesus was named the winner of the 2025 UGA Quick Pitch Event, recognizing his entrepreneurial vision and the company’s innovative cancer therapeutic platform. Read More ›